Bacteria Engineered to Detect Tumor DNA Could Seek and Destroy Gastrointestinal and Other Cancers
By LabMedica International staff writers Posted on 11 Aug 2023 |

Tumors release their DNA into their surrounding environment, a phenomenon known as shedding. While various technologies can analyze purified DNA in laboratory settings, they fall short in detecting DNA in its released state. Although bacteria have been engineered for diverse diagnostic and therapeutic tasks, they cannot recognize specific DNA sequences and mutations outside of cells. Now, researchers have engineered bacteria that can identify tumor DNA in a live organism. This innovation, which successfully detected cancer in the colons of mice, has the potential for the creation of new biosensors to identify infections, cancers, and other diseases.
Under the new “Cellular Assay for Targeted CRISPR-discriminated Horizontal gene transfer,” or “CATCH,” strategy, scientists from the University of California San Diego (La Jolla, CA, USA) used CRISPR technology to engineer bacteria capable of assessing free-floating DNA sequences on a genomic level. These samples were then compared with predetermined cancerous sequences. The concept involved repurposing bacteria that are naturally present in the colon as biosensors, capable of detecting DNA released from colorectal tumors. The focus was on Acinetobacter baylyi, a bacterium in which the essential components for both acquiring DNA and utilizing CRISPR for analysis were identified.
The researchers proceeded to design, construct, and assess Acinetobacter baylyi as a sensor for detecting DNA from the KRAS gene, which is frequently mutated in various cancers. They programmed the bacterium with a CRISPR system to differentiate between mutant and normal (non-mutated) variants of the KRAS gene. Consequently, only bacteria that had incorporated mutant KRAS forms, as present in precancerous growths and cancers, would survive to indicate or respond to the disease. This research builds upon the concept of horizontal gene transfer, a method by which genetic material is exchanged among organisms in a manner distinct from traditional genetic inheritance. While horizontal gene transfer is commonly observed between bacteria, the researchers successfully adapted this concept from mammalian tumors and human cells into bacteria.
The researchers are presently refining their bacteria-based biosensor strategy, exploring new circuits and various bacterial species for detecting and treating human cancers and infections. Researchers believe that in the future, cellular interventions will surpass traditional medicinal approaches. A living bacterium capable of detecting DNA within the gastrointestinal tract holds remarkable potential as a sentinel for identifying and combating gastrointestinal cancers, along with numerous other malignancies.
“There is so much potential to engineer bacteria to prevent colorectal cancer, a tumor that is immersed in a stream of bacteria, that could help, or hinder, its progression,” said researcher Susan Woods.
Related Links:
UC San Diego
Latest Molecular Diagnostics News
- Innovative Bio-Detection Platform Improves Early Cancer Screening and Monitoring
- Blood Test Could Help More Women Survive Aggressive Triple Negative Breast Cancer
- CSF Test Distinguishes Prion Disease from Other Causes of Rapidly Progressive Dementia
- Newly Identified Stroke Biomarkers Pave Way for Blood Tests to Quickly Diagnose Brain Injuries
- CRISPR-Based Test Diagnoses Life-Threatening Fungal Infection More Quickly
- First Of Its Kind Measles Antibody Test Validated for Use with Dried Blood Spot Samples
- Simple Blood Test to Advance Targeted Treatments for Childhood Cancer
- Blood Test to Measure Organ Ageing Could Predict Disease Risk Decades in Advance
- New Test Detects Parasite Responsible for Trichomoniasis Infection In 15 Minutes
- Blood Test to Improve Diagnosis and Management of ALS
- New Technique to Measure Circulating Tumor DNA May Improve Metastatic Cancer Surveillance
- Blood Test Trial Could Unlock New Dementia Treatments
- New Test Measures Biological Age Using Saliva or Blood
- Blood Test Could Identify Expectant Mothers at Risk of Preterm Delivery
- Umbilical Cord Blood Test Could Identify Preterm Infants at Risk for Medical Complications
- Breakthrough Technology Represents Leap Forward in Next-Generation Sequencing
Channels
Clinical Chemistry
view channel
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read more
AI-Powered Raman Spectroscopy Method Enables Rapid Drug Detection in Blood
Accurately monitoring drug levels in the blood is essential for effective treatment, particularly in the management of cardiovascular diseases. Traditional techniques for monitoring blood drug levels often... Read more
Novel LC-MS/MS Assay Detects Low Creatinine in Sweat and Saliva
Timely and accurate monitoring of renal function is essential for managing patients at risk of acute kidney injury (AKI), which affects about 12% of hospitalized patients and up to 57% of ICU patients.... Read more
Biosensing Technology Breakthrough Paves Way for New Methods of Early Disease Detection
Nanopores are tiny openings that can detect individual molecules as they pass through, making them ideal for analyzing biomolecules like DNA and proteins. However, detecting proteins at extremely low ... Read moreHematology
view channel
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read more
WBC Count Could Predict Severity of COVID-19 Symptoms
The global health crisis caused by the SARS-CoV-2 virus continues to impact millions of people worldwide, with many experiencing persistent symptoms months after the initial diagnosis. Cognitive impairment... Read more
New Platelet Counting Technology to Help Labs Prevent Diagnosis Errors
Accurate platelet count testing is a significant challenge for laboratories. Inaccurate results can lead to misdiagnosis, missed diagnoses, and delayed treatment for a variety of potentially fatal conditions,... Read more
Streamlined Approach to Testing for Heparin-Induced Thrombocytopenia Improves Diagnostic Accuracy
Heparin-induced thrombocytopenia (HIT), a serious side effect of the blood thinner heparin, is difficult to diagnose because thrombocytopenia, or low platelet count, can be caused by a variety of factors... Read moreImmunology
view channelCerebrospinal Fluid Test Predicts Dangerous Side Effect of Cancer Treatment
In recent years, cancer immunotherapy has emerged as a promising approach where the patient's immune system is harnessed to fight cancer. One form of immunotherapy, called CAR-T-cell therapy, involves... Read more
New Test Measures Preterm Infant Immunity Using Only Two Drops of Blood
Preterm infants are particularly vulnerable due to their organs still undergoing development, which can lead to difficulties in breathing, eating, and regulating body temperature. This is especially true... Read more
Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer
Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read moreMicrobiology
view channel
Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
Acute infectious gastroenteritis results in approximately 179 million cases each year in the United States, leading to a significant number of outpatient visits and hospitalizations. To address this, a... Read more
Rapid PCR Testing in ICU Improves Antibiotic Stewardship
A collaborative study led by the University of Plymouth (Devon, UK) has shown that rapid polymerase chain reaction (PCR) testing in the intensive care unit (ICU) improved antibiotic stewardship compared... Read morePathology
view channel
Informatics Solution Elevates Laboratory Efficiency and Patient Care
QuidelOrtho Corporation (San Diego, CA, USA) has introduced the QuidelOrtho Results Manager System, a cutting-edge informatics solution designed to meet the increasing demands of modern laboratories.... Read more
Microfluidic Device Assesses Stickiness of Tumor Cells to Predict Cancer Spread
Ductal carcinoma in situ (DCIS), a type of early-stage breast cancer, is often referred to as stage zero breast cancer. In many cases, it remains harmless and does not spread beyond the milk ducts where... Read more
New AI Tool Outperforms Previous Methods for Identifying Colorectal Cancer from Tissue Sample Analysis
Tissue analysis typically involves a pathologist reviewing scanned digital slides from a patient’s intestinal sample and marking specific areas, such as those where cancerous and related tissues are present.... Read moreTechnology
view channel
POC Paper-Based Sensor Platform to Transform Cardiac Diagnostics
Cardiovascular diseases continue to be the leading cause of death worldwide, accounting for over 19 million fatalities annually. Early detection of myocardial infarction (MI), commonly known as a heart... Read more
Study Explores Impact of POC Testing on Future of Diagnostics
In today’s rapidly changing world, having quick and accurate access to medical information is more crucial than ever. Point-of-Care Diagnostics (PoC-D) and Point-of-Care Testing (PoC-T) are making this... Read more
Low-Cost, Fast Response Sensor Enables Early and Accurate Detection of Lung Cancer
Cancer biomarkers are valuable tools for early diagnosis as their concentration in body fluids, such as serum, can be measured to detect the disease at an earlier stage. Additionally, serum levels of these... Read moreIndustry
view channel
CACLP 2025 Unites Global Innovators in IVD Industry
CACLP (Shanghai, China) will be holding the 22nd China International In Vitro Diagnostic Expo, the largest and most influential gathering of the IVD industry in China, 22-24 March 2025 at the Hangzhou... Read more
Bio-Rad to Acquire Digital PCR Developer Stilla Technologies
Bio-Rad Laboratories (Hercules, CA, USA) has entered into a binding offer to purchase all equity interests in Stilla Technologies (Villejuif, France). The acquisition remains subject to consultation with... Read more